Advanced Biomedical Research最新文献

{"title":"Evaluation of Herbal Hair Lotion loaded with Rosemary for Possible Hair Growth in C57BL/6 Mice.","authors":"Asia Begum,&nbsp;Sandhya S,&nbsp;Anoop Kumar N,&nbsp;Syed S Ali","doi":"10.4103/abr.abr_306_21","DOIUrl":"https://doi.org/10.4103/abr.abr_306_21","url":null,"abstract":"<p><strong>Background: </strong><i>Rosmarinus officinalis</i> (rosemary) is a common household plant with needle-like leaves and white flowers that belongs to the family Lamiaceae and has various medicinal properties including ailments of hair and scalp, cardiovascular, nervous disorders, etc., In the current work, we have focused on formulation and evaluation of 1% hair lotion incorporated with methanolic extract of <i>R. officinalis</i>.</p><p><strong>Materials and methods: </strong>The aerial parts of the plant were extracted with methanol and then the nature of phytochemicals were identified by chemical tests. It showed the presence of proteins, amino acids, fats and oils, steroids, glycosides, phenolic compounds, flavonoids, volatile oil, and vitamins. The extract was formulated to a suitable hair lotion and then evaluated for its various quality control parameters. Finally, the lotion was evaluated for hair growth promoting activity on C57BL/6 mice, using water as control and 2% minoxidil hair lotion as standard.</p><p><strong>Results: </strong>It was observed that the formulated 1% herbal hair lotion passed all the evaluation parameters and showed a significant hair growth promoting activity than the standard drug-treated animals.</p><p><strong>Conclusion: </strong>Although several researches have been carried out on the rosemary, an investigation on formulation of hair lotion adding the extract of the aerial part of the plant is for the first time. Since our formulation exhibited an excellent activity, it can be well thought out to be an alternative to the commercially available hair growth promoters with a lot of unwanted effects.</p>","PeriodicalId":7225,"journal":{"name":"Advanced Biomedical Research","volume":"12 ","pages":"60"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/19/6a/ABR-12-60.PMC10186041.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9861850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Are ROMA and HE4 More Accurate than CA-125, in Predicting of Ovarian Epithelial Carcinoma?","authors":"Fariba Behnamfar,&nbsp;Aazam Zafarbakhsh,&nbsp;Narges Ahmadian","doi":"10.4103/abr.abr_264_22","DOIUrl":"https://doi.org/10.4103/abr.abr_264_22","url":null,"abstract":"<p><strong>Background: </strong>Evaluation of ovarian tumors based on tumor markers could have high clinical importance. In this study, we aimed to assess the predictive value of HE4 and Risk of Ovarian Malignancy Algorithm (ROMA) compared to CA-125 in the Malignancy of ovarian epithelial masses.</p><p><strong>Materials and methods: </strong>This cross-sectional study was performed in 2020-2021 including 203 patients. Serum HE4 and CA-125 levels were checked before surgery. According to the pathology report (benign, borderline, or malignant epithelial mass), the predictive values of the three markers were evaluated.</p><p><strong>Results: </strong>About 146 cases were benign; 14 cases were borderline and 43 cases were malignant. Most patients (69.8%) in the malignant group were in stage 3. Significantly higher levels of all three markers (CA-125, HE4, and ROMA) were found in patients with malignant tumors compared to benign or borderline tumors (<i>P</i> < 0.001 for all). The sensitivity of CA-125 was the highest (90.7%) in pre- and post-menopausal patients but the specificity of HE4 and ROMA were higher than CA-125 (98.1% and 97.5%, respectively, versus 86.9% for CA-125). In post-menopausal patients, both sensitivities of HE4 and ROMA were 90.5% and the specificity and sensitivity of CA-125 were the highest (95.2% and 100%). In premenopausal patients, the sensitivity of ROMA (90.9%) and the specificity of HE4 (100%) were the highest.</p><p><strong>Conclusions: </strong>HE4 and ROMA are not necessary for postmenopausal patients in low-resource areas and a check of serum CA-125 will be enough. The higher-cost, ROMA, and HE4 checks are recommended in premenopausal people because they are more sensitive.</p>","PeriodicalId":7225,"journal":{"name":"Advanced Biomedical Research","volume":"12 ","pages":"156"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2a/a0/ABR-12-156.PMC10410412.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9976181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Biotinidase Deficiency in the Second Decade with Atypical Neuroimaging Findings.","authors":"Vykuntaraju K Gowda,&nbsp;Amit Avaragollapuravarga Mathada,&nbsp;Varunvenkat M Srinivasan,&nbsp;Dhananjaya K Vamyanmane","doi":"10.4103/abr.abr_98_22","DOIUrl":"https://doi.org/10.4103/abr.abr_98_22","url":null,"abstract":"<p><p>Biotinidase deficiency is a rare autosomal recessive neurometabolic disorder resulting in biotin deficiency. Our patient presented with seizures and developmental delay since infancy and was started on megavitamin supplements. At 14 years, she presented with motor regression with encephalopathy after discontinuation of vitamins. There were no skin and hair changes. Magnetic resonance imaging (MRI) of the brain showed bilateral symmetrical posterior putamen signal changes. Tandem mass spectroscopy showed increased methyl malonyl carnitine and 3-OH isovaleryl carnitine. There was a low biotinidase level, and a pathogenic variant in the <i>BTD</i> gene in the next-generation sequencing was identified. Special importance is placed on the unusual symmetric posterior putamen involvement seen in MRI of the brain.</p>","PeriodicalId":7225,"journal":{"name":"Advanced Biomedical Research","volume":"12 ","pages":"148"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5b/d4/ABR-12-148.PMC10410414.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9978961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Effect and Safety of Olanzapine on Nausea and Vomiting in Children Receiving Moderately Emetogenic Chemotherapy.","authors":"Aziz Eghbali,&nbsp;Tahereh Bagherloo,&nbsp;Ali Ghasemi,&nbsp;Roghayeh R Afzal,&nbsp;Aygin Eghbali,&nbsp;Kazem Ghaffari","doi":"10.4103/abr.abr_356_22","DOIUrl":"https://doi.org/10.4103/abr.abr_356_22","url":null,"abstract":"<p><strong>Background: </strong>In order to improve the complete recovery of nausea and vomiting, we conducted a study with the aim of preventing acute and delayed nausea and vomiting in children undergoing moderate emetogenic chemotherapy.</p><p><strong>Materials and methods: </strong>A clinical trial study was done on 130 children received chemotherapy. Patients received olanzapine and placebo. All groups received granisetron along with dexamethasone (DEX). The severity of chemotherapy-induced nausea and vomiting (CINV) induced by chemotherapy was compared in two groups.</p><p><strong>Results: </strong>The severity of nausea on the first, second, third, and fourth days was not significantly different (<i>P</i> > .05) in two groups. The number of patients without vomiting was significantly different during the first 24 hours after chemotherapy between patients in the two groups (82.3% vs 64.5%; <i>P</i> = .016).</p><p><strong>Conclusion: </strong>This study showed that olanzapine, which acts as an inhibitor of neurotransmitters, had a favorable efficacy in controlling acute and delayed CINV. More studies with large sample size are needed to compare the effect of olanzapine with other agents including aprepitant and palonosetron in the prevention of CINV.</p>","PeriodicalId":7225,"journal":{"name":"Advanced Biomedical Research","volume":"12 ","pages":"158"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a4/ed/ABR-12-158.PMC10410408.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9981623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Low Current Intensity Plus an Ineffective Dose of Morphine Affect Conditioning Place Preference Through Different Pathways in the Lateral Habenula.","authors":"Elahe Amohashemi,&nbsp;Parham Reisi,&nbsp;Hojjat Allah Alaei","doi":"10.4103/abr.abr_126_22","DOIUrl":"https://doi.org/10.4103/abr.abr_126_22","url":null,"abstract":"<p><strong>Background: </strong>The involvement of lateral habenula and the ineffective dose of morphine on reward-related learning and memory is less well-known. This study looked into the effects of electrical stimulation, GABA_B receptor blockade, and a combination of both with morphine on conditioned place preference.</p><p><strong>Materials and methods: </strong>In this experiment, male rats were anesthetized with ketamine/xylazine (six rats in each group). A 5-day biased conditioned place preference paradigm was used for the behavioral test. The effects of electrical stimulation and phaclofen plus a low dose of morphine on the acquisition and expression phases were examined during conditioning sessions and before the test phase, respectively.</p><p><strong>Results: </strong>The conditioning scores were reduced by antagonist injection during the acquisition phase. Interestingly, different intensities exhibited opposite effects on the acquisition phase. Conditioned place preference scores during the acquisition phase were significantly induced by 25 μA electrical stimulation, while conditioning scores were suppressed by electrical stimulation at 150 μA. Phaclofen (2 μg/rat) combined with high intensity induced aversion during the acquisition phase, while inhibiting expression. In contrast, high intensity with phaclofen (1 μg/rat) inhibited only the acquisition session. However, low intensity during the acquisition phase had an additive effect that was prevented by pretreatment with phaclofen (2 μg/rat), but this response was modified by the antagonist's low dose.</p><p><strong>Conclusions: </strong>A behavioral technique called conditioned place preference is frequently used to evaluate learning that is related to rewards. Therefore, lateral habenula electrical stimulation and phaclofen plus morphine could affect place preference through the involvement of the reward system.</p>","PeriodicalId":7225,"journal":{"name":"Advanced Biomedical Research","volume":"12 ","pages":"161"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2f/ee/ABR-12-161.PMC10410425.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9981624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of Teriparatide on Clinical and Radiologic Long-Term Outcomes after Fixation of Pertrochanteric Hip Fractures.","authors":"Mehdi Hosseini Khameneh,&nbsp;Mona Gorji,&nbsp;Meisam Jafari Kafi-Ababdi,&nbsp;Farsad Biglari,&nbsp;Morteza Gholipour,&nbsp;Keivan Asadi,&nbsp;Amir Sabbaghzadeh","doi":"10.4103/abr.abr_127_22","DOIUrl":"https://doi.org/10.4103/abr.abr_127_22","url":null,"abstract":"<p><strong>Background: </strong>Pertrochanteric hip fractures are common and among serious injuries of the old population with considerable mortality and morbidity. The aim of this study was to evaluate long-term effects of recombinant human parathyroid hormone on postoperative clinical and radiologic outcomes in elderly patients with pertrochanteric hip fractures.</p><p><strong>Materials and methods: </strong>Between 2016 and 2019, we prospectively assessed 80 patients with pertrochanteric hip fractures who underwent reduction and internal fixation with a dynamic hip screw. Patients were divided randomly into two groups. About 40 patients in the control group who received supplementary calcium (1000 mg/day) and vitamin D (800 UI/day), and 40 others who were treated additionally with 20-28 mg daily teriparatide for three months post-operatively. The functional and radiologic assessment was done using visual analog scale (VAS), Harris hip score (HSS), and standard radiographs of the hip.</p><p><strong>Results: </strong>At the final follow-up, there was a significant difference between the two groups regarding average HSS (68.38 in the control group versus 74.12 in the treatment group, <i>P</i>-value <0.001). VAS score was also significantly lower in the treatment group (<i>P</i>-value <0.001). Regarding radiographic evidence of union, the results were not statistically different between the two groups.</p><p><strong>Conclusions: </strong>The current study illustrated that short-term daily administration of teriparatide improves long-term functional outcome after pertrochanteric hip fracture fixation and can reduce the pain but does not affect union and callus formation.</p>","PeriodicalId":7225,"journal":{"name":"Advanced Biomedical Research","volume":"12 ","pages":"139"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/26/aa/ABR-12-139.PMC10331546.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9869906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Novel Missense Mutation in the TGF-β-binding Protein-Like Domain 3 of <i>FBN1</i> Causes Weill-Marchesani Syndrome with Intellectual Disability.","authors":"Mahdieh Hassani,&nbsp;Sara Taghizadeh,&nbsp;Anahita Farahzad Broujeni,&nbsp;Mahvash Habibi,&nbsp;Setareh Banitalebi,&nbsp;Mahbubeh Kasiri,&nbsp;Alireza Sadeghi,&nbsp;Ahoura Nozari","doi":"10.4103/abr.abr_138_22","DOIUrl":"https://doi.org/10.4103/abr.abr_138_22","url":null,"abstract":"<p><strong>Background: </strong>Weill-Marchesani syndrome (WMS) is a rare connective tissue disorder characterized by locus heterogeneity and variable expressivity. Patients suffering from WMS are described by short stature, brachydactyly, joint stiffness, congenital heart defects, and eye abnormalities. This disorder is inherited in two different modes; the autosomal dominant form of the disease occurs due to a mutation in <i>FBN1</i>, and the recessive form results from mutations in <i>ADAMTS10</i>, <i>ADAMTS17</i>, or <i>LTP2</i> genes.</p><p><strong>Materials and methods: </strong>The family recruited in this study was a consanguineous Iranian family with an intellectually disabled girl referred to the Sadra Genetics laboratory, Shahrekord, Iran. The clinical history of family members was investigated. Whole-Exome Sequencing (WES) for the proband was performed. Sanger sequencing was used to assess the segregation of candidate variants in the other family members.</p><p><strong>Results: </strong>Whole-exome sequencing analysis revealed a novel heterozygote mutation in the proband located at the third TGF-β-binding protein-like (TB) domain of the <i>FBN1 g</i>ene (NM000138: c.2066A>G: (p. Glu689Gly), NP_000129.3, in exon 17 of the gene). Co-segregation analysis with Sanger sequencing confirmed this mutation in the affected members of the pedigree.</p><p><strong>Conclusion: </strong>Our findings represent an autosomal dominant form of specific WMS resulting from a substitution mutation in the <i>FBN1 g</i>ene. In addition to the typical manifestations of the disorder, mild intellectual disability (ID) was identified in the 8-year-old proband. Given the fact that ID is primarily reported in <i>ADAMTS10</i> mutated cases, this family was clinically and genetically a novel case.</p>","PeriodicalId":7225,"journal":{"name":"Advanced Biomedical Research","volume":"12 ","pages":"114"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8b/cd/ABR-12-114.PMC10241635.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9590963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Feasibility Study and Design of Registration System for Upper Gastrointestinal Bleeding Patients in Isfahan Province.","authors":"Maryam Soheilipour,&nbsp;Mehdi Kazemi,&nbsp;Behjat Taheri,&nbsp;Peyman Adibi,&nbsp;Ibrahim Abdollahpour","doi":"10.4103/abr.abr_230_21","DOIUrl":"https://doi.org/10.4103/abr.abr_230_21","url":null,"abstract":"<p><strong>Background: </strong>Disease registration is an organized system for collecting, storing, retrieving, analyzing a particular disease or exposure to known substances in a specific population. The aim of this study was to assess the feasibility and design of the registration system for upper gastrointestinal bleeding patients based on patients referring to Al-Zahra and Khorshid hospitals, Isfahan, Iran.</p><p><strong>Materials and methods: </strong>This study is a research action study in which the members of the registration system team are hospital triage physicians, internal residents in the Emergency department of hospital, subspecialty assistants and gastroenterologists, statisticians (epidemiologists and methodologists), and two trained persons were specified to collect medical information and documents. The data collection tool is a researcher-made checklist. Based on the available tools, the most important criteria related to gastrointestinal bleeding were selected. In the next step, the criteria selected in the council, including team members, were reviewed and a preliminary draft was prepared to record the information of patients.</p><p><strong>Results: </strong>The results indicated the final version of the checklist in three parts including demographic variables (age, sex, education, <i>et al</i>.), main variables (as the minimum data required by a person to register in the checklist (patient's clinical signs)), extended main variables (its information is designed to be used to diagnose, treat, and follow-up the patient in later stages).</p><p><strong>Conclusion: </strong>It seems to be predictable by establishing a system for recording gastrointestinal bleeding diseases, disease prevalence, monitoring services and treatment of patients, survival analysis and evaluation of clinical care outcomes, finding patients at higher risk for emergency treatment, reviewing drug interventions, and interventional activities.</p>","PeriodicalId":7225,"journal":{"name":"Advanced Biomedical Research","volume":"12 ","pages":"115"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ca/5d/ABR-12-115.PMC10241624.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9590965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Treatment of Cutaneous Leishmaniasis with Intense Pulsed Light: Is it Effective?","authors":"Amirhossein Siadat,&nbsp;Hamid Galehdari,&nbsp;Zabiholah Shahmoradi,&nbsp;Fariba Iraji,&nbsp;Azadeh Zolfaghari,&nbsp;Nazli Ansari","doi":"10.4103/abr.abr_410_21","DOIUrl":"https://doi.org/10.4103/abr.abr_410_21","url":null,"abstract":"<p><strong>Background: </strong>Cutaneous leishmaniasis (CL) is a common parasitic disorder that is endemic in many countries. There is no completely effective treatment for this condition, but pentavalent antimony compounds are regarded as the main treatment. Different laser types have been used for treatment of CL with variable success but to our best knowledge, there is no published paper regarding use of intense pulsed light (IPL) for treatment of CL.</p><p><strong>Materials and methods: </strong>In this randomized, single-blind clinical trial study, we compared the efficacy of intralesional glucantime alone versus intralesional glucantime plus weekly IPL for treatment of 54 patients with confirmed cutaneous leishmaniasis for a maximum of eight weeks as a randomized, clinical trial.</p><p><strong>Results: </strong>Although it was not statistically significant, combination treatment was more effective than intralesional glucantime alone (<i>P</i> > 0.05). However, the velocity of healing was significantly higher in the IPL plus intralesional glucantime alone versus glucantime alone. No side effect was observed in both groups.</p><p><strong>Discussion: </strong>To better evaluate the efficacy of IPL, more studies with a higher number of patients and using various IPL filters are recommended.</p>","PeriodicalId":7225,"journal":{"name":"Advanced Biomedical Research","volume":"12 ","pages":"125"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9c/d6/ABR-12-125.PMC10331534.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10172600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of Oral Prednisolone on Pain after Tonsillectomy with Sutures: A Randomized Clinical Trial.","authors":"Amin Shayan,&nbsp;Nezammedin Berjis,&nbsp;Sayed Mostafa Hashemi","doi":"10.4103/abr.abr_410_22","DOIUrl":"https://doi.org/10.4103/abr.abr_410_22","url":null,"abstract":"<p><strong>Background: </strong>Tonsillectomy, one of the most common otolaryngology surgeries, often results in postoperative complications such as pain and bleeding. Currently, there is no consensus on postoperative pain management. This study aimed to determine the efficacy of oral prednisolone on postoperative pain after tonsillectomy with sutures.</p><p><strong>Materials and methods: </strong>This pilot, double-blind, randomized clinical trial was conducted at two tertiary care centers affiliated with Isfahan University of Medical Sciences. Patients who underwent tonsillectomy with sutures were included. Participants were randomly divided into experimental and control groups. In the experimental group, patients received oral prednisolone in addition to acetaminophen; in the control group, patients received acetaminophen and a placebo. Post-operative pain was evaluated by a visual analog scale daily for ten days.</p><p><strong>Results: </strong>Initially, 60 patients were enrolled in the study; however, four were excluded due to non-attendance at follow-up visits. The groups were similar in terms of age and sex (both <i>P</i> values >0.05). In the study, postoperative pain from 1^st day to the 10^th day was lower in the experimental group than in the control group (<i>P</i> value <0.05).</p><p><strong>Conclusion: </strong>Numerous studies have been conducted on the effect of intravenous corticosteroids on this pain. However, there is no consensus on the analgesic role of oral corticosteroids for post-tonsillectomy pain. The present study showed that oral prednisolone is effective on post-operative pain compared to a placebo.</p>","PeriodicalId":7225,"journal":{"name":"Advanced Biomedical Research","volume":"12 ","pages":"202"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6e/92/ABR-12-202.PMC10492605.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10223600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}